Pradhan, R. ., Lu, S. ., Yin, H. ., H. Y. Yu, O. ., Ernst, P. ., Suissa, S. ., & Azoulay, L. . (2022). Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study. Bmj, 379, e071380. http://doi.org/10.1136/bmj-2022-071380
O. H. Y. Yu
First name
O.
Last name
H. Y. Yu
Abrahami, D. ., Tesfaye, H. ., Yin, H. ., Vine, S. ., Hicks, B. ., H. Y. Yu, O. ., … Azoulay, L. . (2022). Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study. Diabetes Care. http://doi.org/10.2337/dc22-1174
Brunetti, V. C., St-Jean, A. ., Dell’Aniello, S. ., Fisher, A. ., H. Y. Yu, O. ., Bugden, S. C., … Filion, K. B. (2022). Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom. BMC Endocr Disord, 22, 241. http://doi.org/10.1186/s12902-022-01140-1
Cao, T. X. D., Filliter, C. ., Montastruc, F. ., H. Y. Yu, O. ., Fergusson, E. ., Rej, S. ., … Renoux, C. . (2022). Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. J Affect Disord, 318, 231–237. http://doi.org/10.1016/j.jad.2022.08.094
Pradhan, R. ., Yin, H. ., H. Y. Yu, O. ., & Azoulay, L. . (2022). Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc22-0712
Brunetti, V. C., H. Y. Yu, O. ., Platt, R. W., & Filion, K. B. (2022). The Association of Long-Acting Insulin Analogue Use Versus Neutral Protamine Hagedorn Insulin Use With Major Adverse Cardiovascular Events Among Individuals With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes Obes Metab. http://doi.org/10.1111/dom.14802
Lu, S. ., Yin, H. ., H. Y. Yu, O. ., & Azoulay, L. . (2022). Incretin-Based Drugs and the Incidence of Prostate Cancer Among Patients with Type 2 Diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000001486
Chowdhury, R. ., Michaud, J. ., H. Y. Yu, O. ., Yin, H. ., Azoulay, L. ., & Renoux, C. . (2022). Effectiveness and safety of apixaban vs. rivaroxaban in patients with atrial fibrillation and type 2 diabetes mellitus. Thromb Haemost. http://doi.org/10.1055/a-1798-2116
Pradhan, R. ., Patorno, E. ., Tesfaye, H. ., Schneeweiss, S. ., Yin, H. ., Franklin, J. ., … Azoulay, L. . (2022). Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study. Am J Epidemiol. http://doi.org/10.1093/aje/kwac021
Douros, A. ., Yin, H. ., H. Y. Yu, O. ., Filion, K. B., Azoulay, L. ., & Suissa, S. . (2017). Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events. Diabetes Care. http://doi.org/10.2337/dc17-0595